Preparing your results

Our searching services are busy right now. Your search will reload in five seconds.

X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

The Parkinson disease protein leucine-rich repeat kinase 2 transduces death signals via Fas-associated protein with death domain and caspase-8 in a cellular model of neurodegeneration.

http://www.ncbi.nlm.nih.gov/pubmed/19176810

Neurodegenerative illnesses such as Parkinson and Alzheimer disease are an increasingly prevalent problem in aging societies, yet no therapies exist that retard or prevent neurodegeneration. Dominant missense mutations in leucine-rich repeat kinase 2 (LRRK2) are the most common genetic cause of Parkinson disease (PD), but the mechanisms by which mutant forms of LRRK2 disrupt neuronal function and cause cell death remain poorly understood. We report that LRRK2 interacts with the death adaptor Fas-associated protein with death domain (FADD), and that in primary neuronal culture LRRK2-mediated neurodegeneration is prevented by the functional inhibition of FADD or depletion of caspase-8, two key elements of the extrinsic cell death pathway. This pathway is activated by disease-triggering mutations, which enhance the LRRK2-FADD association and the consequent recruitment and activation of caspase-8. These results establish a direct molecular link between a mutant PD gene and the activation of programmed cell death signaling, and suggest that FADD/caspase-8 signaling contributes to LRRK2-induced neuronal death.

Pubmed ID: 19176810 RIS Download

Mesh terms: Apoptosis | Carrier Proteins | Caspase 8 | Cell Line, Transformed | Fas-Associated Death Domain Protein | Green Fluorescent Proteins | Humans | Mutagenesis, Site-Directed | Neurons | Protein-Serine-Threonine Kinases | RNA, Small Interfering | Transfection

Research resources used in this publication

None found

Research tools detected in this publication

None found

Data used in this publication

None found

Associated grants

  • Agency: NINDS NIH HHS, Id: K02 NS045798
  • Agency: NINDS NIH HHS, Id: K02 NS045798
  • Agency: NINDS NIH HHS, Id: K02 NS045798-01A1
  • Agency: NINDS NIH HHS, Id: R01 NS061098
  • Agency: NINDS NIH HHS, Id: R01 NS061098
  • Agency: NINDS NIH HHS, Id: R01 NS061098-01A1

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.